Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity that Associates with a Clinically Aggressive Subtype of Prostate Cancer

By sjmartinez • March 11, 2025

Zhang L, Teng PC, Cavassani KA, Wang J, Grasso C, Watson J, Chen Z, Tu KH, Salumbides B, Rohena-Rivera K, Gevorkian L, Kim M, You S, Di Vizio D, Sandler HM, Daskivich T, Bhowmick NA, Freeman MR, Tseng HR, Chen JF, Posadas EM. Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity that Associates with a Clinically Aggressive Subtype of Prostate Cancer. Clin Cancer Res. 2025 Mar 10. doi: 10.1158/1078-0432.CCR-24-3660. Epub ahead of print. PMID: 40063516.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

Related Posts

Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension

Alotaibi M, Tang A, Sun N, Gurholt I, Yuguchi E, Roberts K, Preston I, Warburton R, Yuan JX, Kim NH, Chan SY, Jain M, Cheng[...]

Young Women With Pancreatic Cancer: A High-Risk Group for Demoralization

Levi A, Nasr A, Cui Y, Abbas AA, Arouchian TT, Coveler AL, Pierce TL, Anderson BT, Collisson E, Davelaar J, Lo SK, Gaddam S, Gong[...]

Longitudinal Repeated Protein Measurements in a Multiethnic Cohort Identify Novel Diabetes Biomarkers That Reveal Unique Disease Pathways

Chen ZZ, Mi MY, Barber J, Tiwari G, Adams CD, Deng S, Shin CY, Farrell L, Rao P, Cruz DE, Wilson JG, Sevilla-Gonzalez M, Chen[...]